Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,323Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Angelini Pharma Italia United Chemical Companies Angelini Francesc Or Acrafspa Also Enunciable Angel

02 5Angelini Pharma S.P.A.

03 1Angelini Pharma Spa

04 7Angelini Pharma Spa, Rome, Zweigniederlassung Zug

05 3Orifarm AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Cenobamat

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200312000055

Regulatory Info : Approved

Registration Country : Sweden

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Cenobamat

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200312000062

Regulatory Info : Approved

Registration Country : Sweden

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Cenobamat

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 200mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200312000079

Regulatory Info : Approved

Registration Country : Sweden

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Cenobamat

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg;12.5mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200312000024

Regulatory Info : Approved

Registration Country : Sweden

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Cenobamat

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 50mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200312000048

Regulatory Info : Approved

Registration Country : Sweden

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Monastery

Brand Name : Ontozry

Dosage Form : Tablet

Dosage Strength : 12.5mg

Packaging :

Approval Date : 19/05/2022

Application Number : 68051

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Monastery

Brand Name : Ontozry

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Approval Date : 19/05/2022

Application Number : 68051

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Senobamat

Brand Name : Ontozory

Dosage Form : Tablet, film-coated

Dosage Strength : 200 mg

Packaging : Blisterpakning 28item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Senobamat

Brand Name : Ontozory

Dosage Form : Tablet, film-coated

Dosage Strength : 150 mg

Packaging : Blisterpakning 28item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Senobamat

Brand Name : Ontozory

Dosage Form : Tablet, film-coated

Dosage Strength : 50 mg

Packaging : Blisterpakning 28item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank